Woodline Partners’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Hold |
1,503,754
| – | – | 0.01% | 761 |
|
|
2025
Q1 | $2.17M | Buy |
1,503,754
+8
| +0% | +$12 | 0.01% | 651 |
|
|
2024
Q4 | $3.31M | Sell |
1,503,746
-740,614
| -33% | -$1.63M | 0.02% | 567 |
|
|
2024
Q3 | $3.7M | Sell |
2,244,360
-2,805,448
| -56% | -$4.63M | 0.03% | 424 |
|
|
2024
Q2 | $11.2M | Sell |
5,049,808
-2,872,421
| -36% | -$6.38M | 0.11% | 233 |
|
|
2024
Q1 | $21.2M | Buy |
7,922,229
+7,631,847
| +2,628% | +$20.5M | 0.2% | 162 |
|
|
2023
Q4 | $868K | Buy |
+290,382
| New | +$868K | 0.01% | 408 |
|
|
2023
Q2 | – | Sell |
-423,814
| Closed | -$674K | – | 671 |
|
|
2023
Q1 | $674K | Hold |
423,814
| – | – | 0.01% | 505 |
|
|
2022
Q4 | $2.64M | Sell |
423,814
-771,891
| -65% | -$4.81M | 0.04% | 435 |
|
|
2022
Q3 | $8.01M | Buy |
1,195,705
+351,070
| +42% | +$2.35M | 0.11% | 225 |
|
|
2022
Q2 | $5.37M | Buy |
+844,635
| New | +$5.37M | 0.08% | 249 |
|